$Syros Pharmaceuticals (SYRS.US)$ Syros Pharmaceuticals (NAS...
$Syros Pharmaceuticals(SYRS.US$ Syros Pharmaceuticals (NASDAQ:SYRS) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.86) by 88.37 percent. This is a 88.24 percent increase over losses of $(0.85) per share from the same period last year.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment